UBS raised the firm’s price target on Northrop Grumman (NOC) to $770 from $769 and keeps a Buy rating on the shares. Northrop Grumman’s existing portfolio continues to have a strong multi-year growth outlook even before considering upside potential from B-21 reconciliation and repricing, a possible F/A-XX win, and Golden Dome exposure, the analyst tells investors in a research note. The company has taken a prudently conservative outlook on these outcomes, the firm adds.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOC:
- Northrop Grumman price target raised to $680 from $630 at BTIG
- Northrop Grumman price target raised to $690 from $650 at Susquehanna
- Northrop Grumman price target raised to $640 from $575 at JPMorgan
- Elon Musk’s SpaceX Moves $268 Million in Bitcoin as NASA Feud Heats Up
- Northrop Grumman Reports Strong Q3 2025 Results